Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03462719
Brief Title: A Study of the Combination of Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for the First-line Treatment of Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

First Submitted : March 6, 2018
First Submitted that Met QC Criteria : March 6, 2018
First Posted : March 12, 2018

Last Update Submitted that Met QC Criteria : January 16, 2020
Last Update Posted : January 21, 2020